TipRanks
Advertisement
Advertisement
Annexon upgraded to Market Perform from Underperform at Citizens
PremiumThe FlyAnnexon upgraded to Market Perform from Underperform at Citizens
28d ago
Analyst Reiterates Buy on Annexon, Maintains $14 Price Target on Favorable ARCHER II Phase 3 Design
Premium
Ratings
Analyst Reiterates Buy on Annexon, Maintains $14 Price Target on Favorable ARCHER II Phase 3 Design
1M ago
Analyst Reiterates Buy on Enhanced GA Strategy and GBS Upside, Maintaining $8 Price Target
Premium
Ratings
Analyst Reiterates Buy on Enhanced GA Strategy and GBS Upside, Maintaining $8 Price Target
1M ago
Annexon announces tanruprubart data from FORWARD study
PremiumThe FlyAnnexon announces tanruprubart data from FORWARD study
1M ago
Annexon Highlights Promising Early FORWARD GBS Study Results
Premium
Company Announcements
Annexon Highlights Promising Early FORWARD GBS Study Results
1M ago
Annexon Biosciences Secures $200 Million Credit Facility
Premium
Company Announcements
Annexon Biosciences Secures $200 Million Credit Facility
2M ago
Annexon Stockholders Approve Directors, Compensation and Share Increase
PremiumCompany AnnouncementsAnnexon Stockholders Approve Directors, Compensation and Share Increase
3M ago
Annexon initiated with a Neutral at Goldman Sachs
Premium
The Fly
Annexon initiated with a Neutral at Goldman Sachs
4M ago
Annexon: Advancing Complement Pipeline and Strong Cash Runway Support Buy Rating; $11 Price Target Reiterated
Premium
Ratings
Annexon: Advancing Complement Pipeline and Strong Cash Runway Support Buy Rating; $11 Price Target Reiterated
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100